Magazine
Every Disclosed Conflict of Interest at Psychedelic Science 2023
All the financial conflict disclosures from Psychedelics Science 2023 speakers, in one handy list.
Russell Hausfeld
Magazine
Psychedelic Science 2023 Contract Muzzles Speakers: Two Clauses Dictate What Presenters Can and Can’t Say
In order to present at Psychedelic Science 2023, speakers must agree to two out-of-the-ordinary requests about content exclusivity and MAPS’ reputation.
Magazine
Rick Doblin Is No Longer MAPS’ Executive Director. We Didn’t Notice — Did You?
The Multidisciplinary Association for Psychedelic Studies (MAPS) quietly replaced founder Rick Doblin as Executive Director with Kris Lotlikar.
Magazine
Psychedelic Training Provider Fluence Files Trademark for Common Phrase, Walks Back After Criticism
Fluence will no longer seek a trademark for the phrase “Psychedelic Harm Reduction and Integration.”
Magazine
The Misadventures of “Toxic Bob”
Throughout his lifetime, Robert Friedland has evolved from Steve Jobs’ psychedelic guru to mining guru, leaving a trail of environmental destruction in his wake.
Magazine
How To Open Your Wallet: The Hyped and Distorted Claims of Online Psychedelic Marketing
From cultural appropriation to “Shroom Boom,” psychedelic online marketing gaffes and misrepresentations are becoming more and more prevalent from major psychedelic organizations.
Magazine
New Website Details Abuse Allegations Against German Psychedelic Practitioners
A new website — whoisjoeschraube.com — alleges that Joe Schraube and Miguel Delgado have taken advantage of positions of power and abused people under the influence of psychedelics.
Magazine
DoubleBlind Claims Its Ad Was the ‘First-Ever’ U.S. Psychedelic Destigmatization Campaign — It Wasn’t
DoubleBlind claims its recently-unveiled New York City billboard is a lot of things, except what it actually is: a giant advertisement.
Magazine
Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends “Hamilton’s Pharmacopeia” On Vice
Hamilton Morris, the creator of Vice’s “Hamilton’s Pharmacopeia,” will cease working with Vice on the show following the third season. He has joined psychedelic pharmaceutical corporation COMPASS Pathways as a chemistry consultant.
Magazine
COMPASS Pathways’ Psilocybin Patent Questioned By UK Patent Examiner
While COMPASS has issued a response defending the validity of its patents, one of the co-inventors says the patent examiner’s opinion is probably “a valid one.”
Magazine
The Third Wave’s Paul Austin Has Been Accused of Stealing Information For His Psychedelic Provider Directory
The Third Wave copied information from Psychedelic.Support and MAPS Integration List without permission to use for its own directory.
Magazine
COMPASS Pathways Is Trying to Patent Psilocybin for More Mental Health Conditions Than You Can Name
News that COMPASS Pathways is attempting to patent psychedelic therapy room specifications and therapist behaviors started an online firestorm about the company’s “monopolistic and shady behaviors,” but so far the debates have missed the biggest threats lurking in COMPASS’s international patent appl